Research notes from the Onchocerciasis Chemotherapy Research Centre, Ghana

Annals of Tropical Medicine and Parasitology

Volumn 91, Issue 7, 1997, Pages 703-711

  Awadzi, K ^a  

^a Hohoe Hospital   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZIMIDAZOLECARBAMIC ACID DERIVATIVE; ALBENDAZOLE; AMOCARZINE; ANTINEMATODAL AGENT; IVERMECTIN; MEBENDAZOLE;

CHEMOTHERAPY; CLINICAL TRIAL; DRUG SAFETY; EGG SHELL; EMBRYOTOXICITY; GHANA; HUMAN; MEDICAL RESEARCH; MICROFILARIA; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; REVIEW;

ONCHOCERCA VOLVULUS;

EID: 0030666470     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1997.11813193     Document Type: Review

References (14)

1. ANON. (1987) Clinical Orientation CGP 6140: an Antiparasitic Agent (Onchocerciasis). Basle: Ciba Geigy.
2. AWADZI, K., SCHULZ-KEY, H., HOWELLS, R., HADDOCK, D. R. W. & GILLES, H. M. (1982). The chemotherapy of onchocerciasis. VIII. Levamisole in combination with the benzimidazoles. Annals of Tropical Medicine and Parasitology, 76, 460-473.
3. AWADZI, K., DADZIE, K. Y., SCHULZ-KEY, H. HADDOCK, D. R., GILLES, H. M. & AZIZ, M. A. (1985). The chemotherapy of onchocerciasis. X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Annals of Tropical Medicine and Parasitology, 79, 63-78.
4. AWADZI, K., SCHULZ-KEY, H., EDWARDS, G., BRECKENRIDGE, A. M., ORME, M. & GILLES, H. M. (1990). The chemotherapy of onchocerciasis. XIV. Studies with mebendazole-citrate. Tropical Medicine and Parasitology, 41, 383-386.
5. AWADZI, K., HERO, M., OPOKU, N. O., BÜTTNER, D. W. & GILLES, H. M. (1991). The chemotherapy of onchocerciasis. XV. Studies with albendazole. Tropical Medicine and Parasitology, 42, 356-360.
6. AWADZI, K., OPOKU, N. O., BÜTTNER, D. W., COVENTRY, P. A., PRIME, M. A., ORME, M. L. E. & EDWARDS, G. (1994) The chemotherapy of onchocerciasis. XVII. A clinical evaluation of albendazole in patients with onchocerciasis: effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. Tropical Medicine and Parasitology, 45, 203-208.
7. AWADZI, K., OPOKU, N. O., ADDY, K. T. & QUARTEY, B. T. (1995a). The chemotherapy of onchocerciasis. XIX. The clinical and laboratory tolerance of high dose ivermectin. Tropical Medicine and Parasitology, 46, 131-137.
8. AWADZI, K., ADDY, E. T., OPOKU, N. O., PLENGE-BÖNIG, A. & BÜTTNER, D. W. (1995b). The chemotherapy of onchocerciasis. XX. Ivermectin in combination with albendazole. Tropical Medicine and Parasitology, 46, 213-220.
9. AWADZI, K., OPOKU, N. O., ATTAH, S. K., ADDY, E. T., DUKE, B. O. L., NYAME, P. K. & KSHIRSAGAR, N. A. (1997). The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment. Annals of Tropical Medicine and Parasitology, 91, 281-296.
10. GILLES, H. M. & AWADZI, K. (1991). The conquest of river blindness. Annals of Tropical Medicine and Parasitology, 85, 97-101.
11. LECAILLON, J. B., DUBOIS, J. P., AWADZI, K., POLTERA, A. A. & GINGER, C. D. (1990). Pharmacokinetics of CGP 6140 (amocarzine) after oral administration of single 100-1600 mg doses to patients with onchocerciasis. British Journal of Clinical Pharmacology, 30, 625-628.
12. POLTERA, A. A., ZEA-FLORES, G., GUDERIAN, R., BELTRANENA, F., PROAÑO, R., MORAN, M., ZAK, F. & STRIEBEL, H. P. (1991). Onchocercacidal effects of amocarzine (CGP 6140) in Latin America. Lancet, i, 583-584.
13. TAYLOR, H. R., AWADZI, K., GEORGE, T., SCHULZ-KEY, H. & MURPHY, R. P. (1985). Fluorescein angiographic studies of mebendazole treatment for onchocerciasis. Tropical Medicine and Parasitology, 36, 7-11.
14. WORLD HEALTH ORGANIZATION (1987). WHO Expert Committee on Onchocerciasis: Third Report. Technical Report Series No. 752. Geneva: WHO.